| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Formaldehyde |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Acute Toxic Substance |
| DME Modulation |
Formaldehyde inhibits the expression of DME ALDH1B1 |
[1] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Lead |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01505
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Lead inhibits the expression of DME ALDH1B1 |
[2] |
| Tris(1,3-dichloro-2-propyl)phosphate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01031
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of DME ALDH1B1 |
[3] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Apocarotenal |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01523
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Apocarotenal inhibits the expression of DME ALDH1B1 |
[4] |
| Walrycin A |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01498
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Walrycin A up-regulates the expression of DME ALDH1B1 |
[5] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 8 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen inhibits the expression of DME ALDH1B1 |
[6], [7] |
| Arsenic trioxide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Arsenic trioxide up-regulates the expression of DME ALDH1B1 |
[8] |
| Calcitriol |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Calcitriol inhibits the expression of DME ALDH1B1 |
[9] |
| Cisplatin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cisplatin up-regulates the expression of DME ALDH1B1 |
[10] |
| Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate inhibits the expression of DME ALDH1B1 |
[11] |
| Cyclosporine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine inhibits the expression of DME ALDH1B1 |
[12] |
| Leflunomide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00053
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Leflunomide up-regulates the expression of DME ALDH1B1 |
[13] |
| Urethane |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Urethane inhibits the drug-metabolizing activity of DME ALDH1B1 |
[14] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
Bisphenol A inhibits the expression of DME ALDH1B1 |
[15] |
| MS-275 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
MS-275 up-regulates the expression of DME ALDH1B1 |
[16] |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Quercetin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00538
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 1 |
| DME Modulation |
Quercetin inhibits the expression of DME ALDH1B1 |
[17] |
| Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| (+)-JQ1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00723
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug in Preclinical Study |
| DME Modulation |
(+)-JQ1 inhibits the expression of DME ALDH1B1 |
[18], [19] |
| K-7174 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01348
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Patented Pharmaceutical Agent |
| DME Modulation |
K-7174 inhibits the expression of DME ALDH1B1 |
[20] |
|
|
|
|
|
|